How Much Weight Can You Lose Using Ozempic?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, originally developed for type 2 diabetes, has become widely used for weight management because it reduces hunger signals in the brain and slows stomach emptying. Clinical evidence shows that people using semaglutide lose significantly more weight than those on diet and exercise alone, but the amount varies considerably based on individual factors including genetics, starting weight, and medication dosage.

Average Weight Loss Results from Clinical Trials

The STEP trials, which tested semaglutide specifically for weight loss, followed over 4,500 adults without diabetes. Participants receiving the highest dose lost an average of 15.3% of their starting body weight over 68 weeks, compared to just 2.6% in the placebo group. This difference of approximately 12.7 percentage points represents a meaningful clinical advantage that persists beyond the treatment period.

Within the same trial population, approximately 50% of semaglutide users achieved a weight loss of 15% or more, while about 35% reached 20% or greater reductions. These results held across different age groups and baseline weights, though individuals with higher starting body weights sometimes experienced larger absolute pound losses. The consistency of results across diverse patient populations suggests that semaglutide's mechanism is broadly effective rather than limited to specific body types.

Real-world outcomes from clinical practices often mirror or slightly exceed trial results when patients maintain consistent medication use and supportive lifestyle habits. Discontinuation of treatment typically leads to partial weight regain within months, highlighting that semaglutide works as an ongoing therapy rather than a one-time intervention.

Timeline: When Weight Loss Begins and Plateaus

Most people notice appetite suppression within the first week of starting semaglutide, though measurable weight loss typically becomes evident between weeks 2 and 4. This initial phase reflects reduced calorie intake from decreased hunger rather than metabolic acceleration, making dietary consistency during this window particularly important for outcomes.

Significant weight loss momentum typically accelerates between weeks 8 and 16 as the body adjusts to lower food intake and medication effects stabilize. A common pattern involves steady weekly losses of 1 to 2 pounds during this phase, with most users reaching their therapeutic dose by week 16 if following a standard titration schedule. After month 4, the rate of weight loss often slows, with many people experiencing a plateau between months 6 and 12 as the body adapts to the new calorie level.

The weight loss curve typically flattens after 12 months of continuous treatment, meaning additional losses become slower and require either dose optimization or enhanced lifestyle modifications. This plateau is normal physiology, not a sign of treatment failure, and maintaining lost weight at this new level represents a genuine health success.

Factors That Influence Your Individual Weight Loss Amount

Genetic variations significantly influence how your body responds to semaglutide, particularly genes affecting the GLP-1 receptor, GIPR signaling, and metabolic regulation pathways. PlexusDx Precision Peptide Genetic Test identifies your specific genetic predispositions across 14 metabolic pathways and 49 peptides, revealing whether you carry variants like GLP1R rs6923761 or GIPR rs1800437 that may affect medication response. Understanding your genetic profile helps predict whether you're likely to achieve above-average or below-average weight loss, allowing for proactive dose or treatment adjustments.

Baseline body weight is another critical predictor—individuals with higher starting weights often lose more pounds in absolute terms, though the percentage of body weight lost tends to be similar across weight categories. Age, existing metabolic conditions, prior weight loss attempts, and current medications all interact with semaglutide's effects, creating a complex individual response pattern.

Lifestyle factors including physical activity, dietary quality, sleep duration, and stress management amplify or diminish medication effects. Semaglutide works best as part of a comprehensive approach rather than as a standalone intervention, and people who combine it with structured nutrition guidance typically achieve results at the higher end of clinical ranges.

Realistic Expectations: What You Should Actually Plan For

A reasonable individual goal is to lose between 10% and 20% of starting body weight within the first year, though some people achieve more and others less depending on the factors above. Setting your personal target at 1 to 2 pounds per week during active loss phases helps maintain motivation while avoiding disappointment if your individual response differs from average trial populations.

Plateaus lasting 4 to 8 weeks are completely normal and do not indicate treatment failure or resistance. During these periods, the focus should shift to maintaining current weight, improving body composition through strength training, and ensuring medication adherence rather than expecting continued scale decreases.

Long-term success with semaglutide depends on viewing it as an ongoing tool rather than a temporary fix. People who regain the most weight typically discontinue treatment, while those maintaining consistent use sustain 75% to 80% of their weight loss years after starting. PlexusDx Semaglutide Injection starts at $149 per month across all dose levels, with dosing optimized through regular monitoring to maximize your individual response potential.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I expect to lose in the first month?

Most people lose 2 to 4 pounds in month one as appetite decreases and calorie intake drops. This early loss is primarily from reduced food consumption rather than metabolic changes, making it important to maintain consistent medication use even if weight loss seems slow initially.

Is a 15% weight loss really achievable, or is that just trial average?

A 15% reduction is an average, not a guarantee, but it is achievable for many people. About 50% of semaglutide users in major trials hit this milestone, and real-world outcomes suggest similar or slightly better rates when patients maintain consistent adherence and supportive lifestyle habits.

Why do some people lose more weight than others on semaglutide?

Genetic variations in GLP-1 receptor pathways, GIPR signaling, and metabolic regulation significantly influence individual response. PlexusDx Precision Peptide Genetic Test reveals these predispositions across 14 pathways, helping explain why your results may differ from published averages and guiding treatment optimization.

Can PlexusDx help me achieve better weight loss results than I would on my own?

PlexusDx Semaglutide Injection starts at $149 monthly across all doses, with personalized optimization through the Precision Peptide Genetic Test ($99 add-on).

What happens to weight loss after I stop semaglutide?

Most people regain 30% to 50% of lost weight within 12 months of discontinuing semaglutide, though long-term maintenance is possible if lifestyle changes have been sustained.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.